SPLASH BEVERAGE GROUP INC
SBEVNYSE AMERICANTrading Snapshot
- Day Range
- $0.47 – $0.48
- 52-Week Range
- $0.25 – $13.40
- Volume
- $2.61B
- Avg Volume
- $3.26B
- Shares Outstanding
- 11.0M
- Next Earnings
- Nov 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $73,066
- Last Q Revenue
- $20,322
- P/E Ratio
- -0.0
- P/S Ratio
- -14.3x
- EPS (TTM)
- $-5.64
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +36.3%
Why Investors Own SBEV
- ✓High-growth profile — revenue up +25.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 66% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SPLASH BEVERAGE GROUP INC
SBEV
StockOtter · stockotter.spaceAbout SPLASH BEVERAGE GROUP INC
Based in Fort Lauderdale, Florida, Splash Beverage Group, Inc. operates within the U.S. beverage market, focusing on the production, distribution, promotion, and retail of a diverse selection of drinks. Their product portfolio features SALT Naturally Flavored Tequila, the TapouT Performance line of isotonic sports drinks designed for hydration and recovery, Copa di Vino wines, and Pulpoloco Sangria. In addition to traditional sales channels, the company also utilizes its e-commerce platform, qplash.com, to sell both beverages and groceries directly to consumers online.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
Endovia Health Sciences believes the federal government's affirmative support for Schedule III represents a significant evolution in U.S. cannabinoid poli
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE American: EDVA), formerly Splash Beverage Group, Inc. (NYSE American: SBEV) ("Endovia Health" or the "Company") announced that
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
FORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health Sciences, Inc., and its com
Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences
FORT LAUDERDALE, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”) today reported financial results for the second quarter ended June 30, 2026, and prov
Splash Beverage Group to Rebrand as Endovia Health Sciences
FORT LAUDERDALE, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced its intention to change its corporate name to Endovia Health Sciences, Inc., effe
Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway
Collaboration with Lupvindol Biosciences will initially target companion-animal oncology and chronic pain management Splash retains ownership of resulting data, intellectual property and commercialization rights FORT LAU